Table 5 Identified multi-resistant bacteria in diagnosis sample
COVID + (n; %) | COVID- (n; %) | p-value | ||
|---|---|---|---|---|
Multi-Resistant Bacteria (n; % of bacteria with complete antibiogram) | Presence (n = 166) | 87 (13.8) | 79 (40.1) | < 0.05 |
Methicillin-resistant Staphylococcus aureus (n; % of bacteria with complete antibiogram) | Presence (n = 16) | 13 (10.0) | 3 (12.0) | – |
Ceftazidime-resistant Pseudomonadaceae (n; % of bacteria with complete antibiogram) | Presence (n = 21) | 17 (12.0) | 4 (22.2) | – |
Beta-lactam-resistant Acinetobacter sp. (n; % of bacteria with complete antibiogram) | Presence (n = 5) | 4 (33.3) | 1 (50.0) | – |
Vancomycin-resistant Enterococcae (n; % of bacteria with complete antibiogram) | Presence (n = 0) | 0 (0) | 0 (0) | – |
Extended-spectrum beta-lactamase-producing Enterobacterales (n; % of bacteria with complete antibiogram) | Presence (n = 48) | 46 (12.2) | 2 (2.8) | < 0.05 |
Carbapenemase-producing Enterobacterales (n; % of bacteria with complete antibiogram) | Presence (n = 7) | 7 (0.2) | 0 (0) | – |